A number of top pharma companies are being investigated for of the US Foreign Corrupt Practices Act (FCPA) – some for the second time. The list includes names like GlaxoSmithKline, Teva Pharmaceutical Industries Ltd., Sanofi, AstraZeneca, UCB, Novartis, Novo Nordisk, Eli Lilly. ...